A novel score calculated based on markers of liver and heart health may help to predict the risk of future…
Articles by Marisa Horak, MS
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to IKT-001, an experimental formulation of imatinib that…
People with pulmonary arterial hypertension (PAH) have less diversity among the viruses that infect bacteria in their digestive tracts,…
Respiratory rehabilitation is safe and can help improve exercise capacity in people with chronic obstructive pulmonary disease (COPD) with…
Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears…
Note: This story was updated May 28, 2026, to clarify the indications for which Cereno Scientific’s experimental therapies are being…
Using artificial intelligence (AI) analyses of clinical data from hundreds of patients, scientists have created a new system to calculate…
Using artificial intelligence (AI) and analyzing genetic data focused on two primary biochemical processes, a team of scientists in China…
A team of scientists in China identified four genes that may serve as potential treatment targets for idiopathic pulmonary…
Scientists in China have developed a phosphodiesterase-5 (PDE5) inhibitor for pulmonary arterial hypertension (PAH) that reduced disease severity in…
Advocates worldwide are gearing up for World Pulmonary Hypertension Day on May 5, focusing this year on the critical…
Babies with bronchopulmonary dysplasia (BPD), a lung disorder that affects premature infants and can lead to pulmonary hypertension (PH),…